Clozapine-induced nephritis and monitoring implications

dc.contributor.authorMohan, T.
dc.contributor.authorChua, J.
dc.contributor.authorBastiampillai, T.
dc.contributor.authorDhillon, R.
dc.date.issued2013
dc.description.statementofresponsibilityTitus Mohan, Joseph Chua, Joshua Kartika, Tarun Bastiampillai, and Rohan Dhillon
dc.identifier.citationAustralian and New Zealand Journal of Psychiatry, 2013; 47(6):586-587
dc.identifier.doi10.1177/0004867412470170
dc.identifier.issn0004-8674
dc.identifier.issn1440-1614
dc.identifier.urihttp://hdl.handle.net/2440/79949
dc.language.isoen
dc.publisherBlackwell Publishing Asia
dc.rightsCopyright status unknown
dc.source.urihttps://doi.org/10.1177/0004867412470170
dc.subjectHumans
dc.subjectNephritis, Interstitial
dc.subjectClozapine
dc.subjectAntipsychotic Agents
dc.subjectKidney Function Tests
dc.subjectFemale
dc.titleClozapine-induced nephritis and monitoring implications
dc.typeJournal article
pubs.publication-statusPublished

Files